16:50 EDT NLS Pharmaceutics (NLSP) files to sell 5M common shares for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NLSP:
- NLS Pharmaceutics Engages New Accounting Firm After Marcum’s Resignation
- NLS Pharmaceutics and Kadimastem Secure SEC Approval for Merger
- NLS Pharmaceutics and Kadimastem Secure Hong Kong Patent for Diabetes Therapy
- NLS Pharmaceutics and Kadimastem granted patent in Hong Kong for diabetes
- NLS Pharmaceutics Extends Merger Agreement with Kadimastem